Here's Why Cardinal Health (CAH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Jun 1, 2026

Wall Street Analysts Predict a 25.75% Upside in Cardinal (CAH): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 25.8% in Cardinal (CAH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Jun 1, 2026

Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Zacks Investment Research • May 27, 2026

Is Cardinal Health (CAH) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • May 27, 2026

Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • May 27, 2026

CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?

CAH and COR are betting big on specialty pharma, but Cardinal Health???s stronger growth, raised outlook, and broader expansion may set it apart.

Zacks Investment Research • May 27, 2026

Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • May 25, 2026

Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?

CAH's fast-growing Other Growth Businesses posted 34% revenue growth and 52% profit gains, raising their role in long-term earnings.

Zacks Investment Research • May 25, 2026

3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • May 20, 2026

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

Cardinal Health's specialty growth, strong cash flow and expanding higher-margin businesses are boosting earnings momentum despite IRA and GMPD risks.

Zacks Investment Research • May 20, 2026